Blog

Blog2018-05-01T17:49:07+00:00
16Nov 2017

ELI LILLY in the Diabetes Market

November 16th, 2017|Categories: Business, Chronic Disease, Diabetes|0 Comments

For years, Eli Lilly’s main contributions to the Diabetes market were their insulins: fast acting analog Humalog® and human insulin Humalin and two premix offerings in analog Humalog® Mix 50/50 and human premix Humalin 75/25. Despite a legacy category, this portfolio of insulins continues to drive significant revenue with over [...]

19Oct 2017

DIABETES PIPELINE ANALYSIS – NOVO NORDISK

October 19th, 2017|Categories: Chronic Disease, Diabetes|Tags: , , |0 Comments

Novo Nordisk remains a top player in the Diabetes market with blockbuster insulins NovoLog®  and Levemir® which brought in a combined almost $3.5 billion in 20166, Victoza® a GLP-1 that brought in $2.1 billion in 20166, and recently launched Basal insulin/GLP-1 combination product Xultophy®,  which is expected to reach $1.2 [...]

28Aug 2017

DIABETES PIPELINE ANALYSIS – MERCK

August 28th, 2017|Categories: Business, Data Analytics, Diabetes|0 Comments

Merck’s two blockbuster diabetes products, Janumet® and Januvia®, are DPP-4 inhibitors that generated nearly $3.3 billion in Sales in 2016.3 Januvia® is especially known for its great cardiovascular safety profile, which has helped differentiate itself in its class. But Merck has no plans of stopping there with four different products [...]

4Aug 2017

WHAT DO THE BIG PLAYERS HAVE IN STORE FOR THE DIABETES MARKET IN THE NEXT 12 MONTHS?

August 4th, 2017|Categories: Chronic Disease, Diabetes|0 Comments

Diabetes is one of the most prevalent diseases in the U.S., afflicting over 29 million people across Type 1 and Type 2 patients, according to the CDC1 and represents over a $50 billion dollar industry2. Pharmaceutical companies are constantly racing to create the next market leader, and 2018 will be [...]

2Aug 2017

Letting the Data Tell the Story

August 2nd, 2017|Categories: Business, Data Analytics|Tags: , , |0 Comments

In our previous post we described the technique for assigning categories to data, based on input from content experts within a “training database”.  This technique is effective for summarizing large, text-heavy data into specific categories for summaries and improved visualization.  While this approach is useful for those purposes, it will [...]

24Jul 2017

USING NLP TECHNIQUES TO CLASSIFY PATIENT SEGMENTS IN CLINICAL TRIAL DATA

July 24th, 2017|Categories: Business, Data Analytics|Tags: , , |0 Comments

One of the most common and powerful approaches in NLP provides the content experts an opportunity to label each data segment for a portion of the dataset and then analyze these labels to apply to the rest of the dataset. Some key questions need to be answered when applying this [...]